Israel’s Rabin medical center has established the only special clinic in israel to perform genetic screening to treat and prevent cancer. The BRCA Multidisciplinary Clinic was created to serve patients with a high risk of cancer at Rabin Medical Center’s Davidoff Cancer Center. Since its commencement in 2011, the clinic has served thou - sands of women. Women who carry the BRCA gene mutation have up to an 80% chance of developing breast and/or ovarian cancer. More than 200 mutations have been identi - fied, three of which are typical to Ashkenazi Jews. There is a 2.5% risk of carrying this mutation. One out of every forty Jewish Ashkenazi women is a carrier and has a high probability of developing ovarian and/or breast cancer. At the Rabin Medical Center BRCA Clinic, patients receive counseling, screening and follow-up care. With breast cancer at such a high rate in Israel, affecting about 31% of women suffering from malignant dis eases, the BRCA Multidisciplinary Clinic is essential to saving lives.
The BRCA Multidisciplinary Clinic also treats men with prostate cancer. Research data indicates that men carry mutations in the BRCA 1 and 2 genes, similar to the syn - drome for breast and ovarian cancer in women. Three thousand new cases of prostate cancer are diagnosed in Israel annually, with four hundred fatalities.
For the first time in Israel, at Rabin Medical Center Stereotactic Body Radiation (SBRT) treatment is available for certain lung cancer patients using the Trilogy Linear Accelerator, the most advanced accelerator available today.
The Sixth Annual Cheryl Diamond NYC 5k Schlep Run / Walk in Battery Park on June 5, 2016 highlighted the BRCA Gene Multidisciplinary Clinic, serving women at high risk of breast and ovarian cancer.
Israel's Rabin Medical Center’s Dr. Daniel Goldstein explores the rising price of cancer medications and creates an equation to see if the cost is in fact justified. Dr. Daniel Goldstein, a rising medical star in the United States, is at the front lines in the fight against the outrageous price of cancer medications.